Biocon appoints Peter Bains as group CEO

He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news